These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33176842)

  • 21. Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trial.
    Trevillyan JM; Dart A; Paul E; Cavassini M; Fehr J; Staehelin C; Dewar EM; Hoy JF; Calmy A
    AIDS; 2021 Mar; 35(4):619-624. PubMed ID: 33252480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.
    Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
    Curr Med Res Opin; 2007 Mar; 23(3):641-8. PubMed ID: 17355745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
    Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yokoi H; Yoshida M;
    Circ J; 2012; 76(1):221-9. PubMed ID: 22094911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
    Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yokoi H; Yoshida M;
    Circ J; 2013; 77(6):1526-33. PubMed ID: 23486191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosuvastatin: a review of its effect on atherosclerosis.
    Keating GM; Robinson DM
    Am J Cardiovasc Drugs; 2008; 8(2):127-46. PubMed ID: 18422395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G; Vitulano N; Mancini B; Zanasi A; D'Orazio N
    Pharmacology; 2010; 85(2):63-7. PubMed ID: 20110750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study.
    Peters SA; Palmer MK; Grobbee DE; Crouse JR; Evans GW; Raichlen JS; Bots ML;
    J Hypertens; 2011 Jun; 29(6):1145-54. PubMed ID: 21546878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis].
    Feng X; Zhang J; Liu M; Li X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):247-53. PubMed ID: 24831484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
    Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
    Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin effect on intima media thickness in adult vs elderly patients.
    Riccioni G; Scotti L; Di Ilio E; Bucciarelli V; D'Orazio N; Aceto A; Bucciarelli T
    Front Biosci (Elite Ed); 2012 Jun; 4(7):2618-21. PubMed ID: 22652672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carotid intima-media thickness in children with familial hypercholesterolemia.
    Kusters DM; Wiegman A; Kastelein JJ; Hutten BA
    Circ Res; 2014 Jan; 114(2):307-10. PubMed ID: 24192652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
    Liu Z; Zhao Y; Wei F; Ye L; Lu F; Zhang H; Diao Y; Song H; Qi Z
    Atherosclerosis; 2014 Mar; 233(1):291-9. PubMed ID: 24495792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of rosuvastatin in the management of dyslipidemia.
    Rubba P; Marotta G; Gentile M
    Vasc Health Risk Manag; 2009; 5(1):343-52. PubMed ID: 19436657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.
    Igase M; Kohara K; Tabara Y; Nagai T; Ochi N; Kido T; Ochi M; Miki T
    Menopause; 2012 Dec; 19(12):1294-9. PubMed ID: 22850442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects).
    Takayama T; Hiro T; Yamagishi M; Daida H; Saito S; Yamaguchi T; Matsuzaki M
    Circ J; 2007 Feb; 71(2):271-5. PubMed ID: 17251680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
    Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.
    Kurabayashi M; Sakuma I; Kawamori R; Daida H; Yamazaki T; Yoshida M; Hata M; Masuda I; Kaku K; Yokoi H; Kishimoto J; Nohara R
    J Atheroscler Thromb; 2010 Apr; 17(4):416-22. PubMed ID: 20215710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of variability in ultrasound settings on the measured echolucency of the carotid intima-media.
    Peters SA; Bots ML; Lind L; Groenewegen KA; de Korte C; den Ruijter HM;
    J Hypertens; 2013 Sep; 31(9):1861-7. PubMed ID: 23868083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.